Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3588]

Blocking a 'jamming signal' can unleash immune system to fight tumours

Blocking a 'jamming signal' can unleash immune system to fight tumours

Research uncovers clues in use of immunotherapy for breast cancer

Research uncovers clues in use of immunotherapy for breast cancer

FDA approves pembrolizumab for cutaneous squamous cell carcinoma

FDA approves pembrolizumab for cutaneous squamous cell carcinoma

Researchers find that common cancer treatments don't worsen coronavirus infection

Researchers find that common cancer treatments don't worsen coronavirus infection

AACR 2020: Personalised cancer vaccine plus atezolizumab shows clinical activity in patients with advanced solid tumours

AACR 2020: Personalised cancer vaccine plus atezolizumab shows clinical activity in patients with advanced solid...

AACR 2020: Real-world data shows immunotherapy after melanoma surgery yields survival benefit

AACR 2020: Real-world data shows immunotherapy after melanoma surgery yields survival benefit

Early clinical trial supports tumour cell-based vaccine for mantle cell lymphoma

Early clinical trial supports tumour cell-based vaccine for mantle cell lymphoma

Vitamin D may help prevent a common side effect of anti-cancer immunotherapy

Vitamin D may help prevent a common side effect of anti-cancer immunotherapy

Combination biomarker predicts response to immune checkpoint therapy in patients with advanced bladder cancer

Combination biomarker predicts response to immune checkpoint therapy in patients with advanced bladder cancer

FDA approves gemtuzumab ozogamicin for CD33-positive AML in paediatric patients

FDA approves gemtuzumab ozogamicin for CD33-positive AML in paediatric patients

More from ecancer